InvestorNewsBreaks – DarioHealth Corp.’s (NASDAQ: DRIO) Solutions Selected by National Employer
December 5, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a new contract to provide cardiometabolic and GLP-1 solutions to a national employer beginning in January 2024. The national logistics company selected Dario to deliver integrated support for employees living with diabetes, pre-diabetes, weight management and hypertension, while also providing a tailored […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Hypertension Offering Selected by Blue Shield of California
November 29, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has been selected by Blue Shield of California to expand the nonprofit health plan’s services. According to the announcement, Blue Shield of California is adding Dario’s at-home solution for high blood pressure, or hypertension, that combines personalized health coaching and tech-enabled monitoring. The addition […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks New Cardiometabolic Solution Contract with National Company
November 27, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has entered into a new contract outlining plans to provide is cardiometabolic solution to an employer. The contract will begin in January 2024. The new contract is the latest is a growing number of similar agreements, indicating that demand for Dario’s integrated solutions continues […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) New Research Sheds Light on Mediators of Improved Outcomes in Dario Users
November 21, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced two new analyses presented by Sanofi U.S. demonstrating two mediators associated with improved clinical and economic results in Dario users. According to the announcement, presentations by Sanofi U.S. at the Diabetes Technology Society (“DTS”) annual conference, held Nov. 2 – 4, examined […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Study Showing Connection Between Increased Physical Activity, Reduced Blood Glucose
November 13, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on new research presented last week at the Diabetes Technology Society 2023 Meeting. According to the announcement, the new study demonstrates the value of associating physical activity tracking alongside blood sugar tracking for people living with diabetes and prediabetes; the results emphasize […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q3 2023 Results
November 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the third quarter 2023 and provided a corporate and commercial update. “As we discussed during our recent investor day, our revenue generally comes from three sources, our historical direct to consumer (‘B2C’) business, recurring revenue from health plans and […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Innovative Smart Blood Glucose Meter
November 1, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced the launch of a new smart blood sugar meter for Apple iPhone 15 users to support ongoing engagement with new and existing members. As recently reported, the new iPhone 15 is built with a USB-C charging port, which is a key element […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q3 2023 Financial Results
October 30, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be releasing its financial results for Q3 2023 on Nov. 2, 2023, before the market opens. In addition, the company also announced plans to host a conference call and webcast the same day at 8:30 a.m. ET. According to the announcement, DarioHealth CEO […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Digital Health Solution Indicates Less-Costly Use of Hospital-Related Utilization, Study Shows
October 17, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on award-winning new research conducted by Sanofi U.S. that indicates the company’s ability to reduce costs through lower utilization of expensive healthcare resources. Sanofi US reported the research at the Academy of Managed Care Pharmacy’s 2023 annual conference Nexus (“AMCP-Nexus”). According to […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Selected as Preferred Partner by Top Five National Employee Benefits Consulting Firm
October 5, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has announced a new strategic partnership with a top five national employee benefits consulting firm, to become the preferred digital health and chronic condition solution partner for its national employer clients. According to the announcement, the firm selected Dario for its proven ability to […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Showcase Rise of Digital Health at Upcoming Investor Day
October 3, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced that it will host an in-person investor day in New York. The event is slated to take place beginning at 11 a.m. ET on Oct. 17, 2023, at the offices of Sullivan & Worcester LLP. Interested parties should visit https://ibn.fm/Bal6S to pre-register […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces New Research Evidencing Value of Digital Behavior Health Programs
September 27, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has announced new findings published in the Journal of Medical Internet Research (“JMIR”) demonstrating the impact of coaching and breathing exercises as part of the Dario digital behavioral health program for members living with depression or anxiety. The study analyzed the data of participants […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes New Research Backing Its Approach to Outcome-Based Engagement
August 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced new research presented at the ADCES23 Annual Conference that took place earlier this month in Houston, Texas. According to the announcement, the research demonstrates Dario’s ability to sustainably improve health outcomes for users with diabetes over a two-year period. “Dario’s solutions are […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with PlanSource to Provide Key Digital Health Solutions
August 15, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has inked a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology. The agreement, which expands Dario’s reach in the employer market, calls for the company to offer integrated digital health solutions to more than 5 million consumers. Dario’s […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q2 2023 Results
August 10, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the second quarter 2023 and provided a corporate and commercial update. “During the second quarter, we saw a continuation of the many positive trends that have contributed to our improved financial profile, including growing revenue contribution from highly scalable […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Agreement with Large Regional Health Plan
August 8, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced the expansion of its partnership with a large regional health plan to deliver highly personalized digital health solutions to plan members living with diabetes. The launch is anticipated to take place in the first quarter of 2024. “Our ability to engage members […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q2 2023 Results, Conference Call and Webcast
August 3, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced that it will release its financial results for the second quarter ended June 30, 2023, before market opens on Thursday, Aug. 10, 2023. Also on Aug. 10, the company will host a conference call and webcast at 8:30 a.m. Eastern Time, led […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Behavior Program to Support Weight Loss, Better Health
August 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is offering a new program designed to provide support for individuals using GLP-1s and other anti-obesity drugs. The program is designed to support changes in behavior and help users leverage the full potential of medications while improving overall health; the program also has potential […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Shares New Research Supporting Significant Medical Costs Savings for Dario Users
July 26, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a new analysis by Sanofi U.S. demonstrating a significant reduction in the cost of care for Dario users compared to non-users living with type 2 diabetes. According to the announcement, the study used matched claims to show an estimated $5,077 in medical […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Large Regional Health Plan to Client List, Reports on Q2 2023 Preliminary Results
July 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has added a new agreement with a large regional health plan to its client list. According to the announcement, DRIO will deliver highly personalized digital health solutions to more than 160,000 plan members living with hypertension; the plan will launch this month. DRIO noted […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds New Full-Suite Employer to Growing Number of Contracts
July 6, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is adding a new employer contract to its growing list of clients. The new full-suite account is scheduled to launch later this year, and the company expects it to add to revenue for the year. According to the company, the new account is a […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Key Research Presented at ABA Scientific Sessions
June 26, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, reported on a retrospective cohort study at the recent American Diabetes Association (“ABA”) 83rd Scientific Sessions. According to the announcement, the study analyzed real-world data of Dario users against matched controls, with results showing significant improvements in HbA1c for Dario users with serious diabetes. […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Two New Contracts for Integrated Solutions
June 7, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced two new employer contracts for the company’s full suite of integrated solutions. According to the update, the new accounts are scheduled to launch in the second half of 2023. “Managing the rising cost of chronic conditions with a significant return on investment […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO to Present at Upcoming Stifel Virtual Cross Sector Insight Conference
June 1, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be attending and participating in the Stifel 2023 Virtual Cross Sector Insight Conference. The two-day event is scheduled to be held in Boston on June 6–7, 2023. According to the announcement, DarioHealth president Rick Anderson will be presenting at the conference; his presentation […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Solutions to MedOne Members
May 18, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global health market, and MedOne Pharmacy Benefit Solutions (“PBM”), a national leader in modern pharmacy benefits management, today announced a new agreement to integrate Dario’s suite of digital health solutions as a complement to MedOne’s digital diabetes solution, the Diabetes Care Path. According to the update, the collaboration […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q1 Financial and Operating Results
May 11, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced financial results for the first quarter 2023 and provided a corporate and commercial update. “During the first quarter, we continued to improve the financial profile of the company as we capitalized on the growing demand for digital health solutions in the […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Research Presented at Leading Global Conference for Health Economics
May 9, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, announced the presentation of research at ISPOR 2023, the leading global conference for health economics and outcomes research. The conference was on May 7–10, 2023, in Boston. The research presented came from a retrospective cohort study that analyzed real-world data of users and nonusers […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Upcoming Release of Q1 2023 Financial Results, Schedules Earnings Call
May 4, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, plans to reports on its financial results for the first quarter ended March 31, 2023; the company will release the report on May 11, 2023, before market open. In addition, DarioHealth has scheduled an earnings conference call and webcast to discuss the report. The event […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Private Placement Pricing, Announces Credit Facility Refinance
May 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced the pricing of a $14.3 million private placement of convertible preferred stock. The announcement noted that the placement had been priced at the market under NASDAQ rules and included “significant participation by select members of leadership, the board and existing investors.” In addition, DarioHealth […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Appoints Digital Health Product Leader as Chief Product Officer
April 4, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that digital health veteran, Eitan Shay, is joining the company in the newly created position of chief product officer. Shay previously served in product leadership roles at digital health companies Livongo and Teladoc Health, as well as senior leadership roles at […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Digital Therapeutics Contract with Top-10 PBM
March 27, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has inked a new deal with a leading nationwide pharmacy benefits manager (“PBM”), the first contract that has resulted from the company’s strategic partnership with Sanofi U.S. The PBM operates in 50 states, and the agreement notes that the organization will begin the […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Amwell to Offer Valuable Access to Cardiometabolic Digital Therapeutic Solution
March 22, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has entered a new agreement with Amwell(R) (NYSE: AMWL), a leader in digital healthcare enablement. The agreement outlines the delivery of DRIO’s cardiometabolic solution to Amwell customers, with the potential to reach more than 90 million users; availability of the platform is anticipated to […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Study Results Published, Shows Potential for Digital Therapeutics in Pain Management
March 14, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting about new research related to machine learning and digital health solutions. The research, which was published in “Pain Reports,”evaluated the personalized efficacy of digital therapeutics for pain management, linking the reduction of back pain for users in a digital posture training. […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q4 and FY 2022 Results
March 9, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today reported financial results for the fourth quarter and full year 2022 and provided a corporate and commercial update. “During the fourth quarter, we continued to see substantial improvements in our financial results driven by our pivot to a business-to-business (‘B2B’) business model, […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Date for Execs to Host Q4 2022 Results Call
March 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has scheduled a date to release its fourth-quarter financial results for the period ended Dec. 31, 2022. DRIO CEO Erez Raphael, president Rick Anderson and CFO Zvi Ben-David will host the conference call and webcast on March 9, 2023; the event is slated […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Clinical Outcomes in Two New Studies at Diabetes Conference
February 27, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, reported on the results of two new clinical studies at the 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD); the event was held Feb. 22–25, 2023, in Berlin. Specifically, the company reported that one study demonstrated improved clinical outcomes in users […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) DarioHealth to Participate in Upcoming Cowen Health Care Conference
February 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that management will participate in the Cowen 43rd Annual Health Care Conference. The event is slated to take place March 6-8, 2023, at the Boston Marriott Copley Place in Boston, Massachusetts. The company’s CEO Erez Raphael and President Rick Anderson will […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Board Appointment of Health Care Industry Veteran
February 23, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced the appointment of Jon Kaplan to serve as a board member, effective immediately. As a managing director and senior partner at Boston Consulting Group (“BCG”), Kaplan serves as a core member of the strategy and health care practices and leading BCG’s […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expanding Platform to Integrate Market-Leading CGM Data
February 8, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced an agreement with DexCom (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (“CGM”) technology, to integrate its market-leading CGMs into Dario’s multi-chronic condition platform. “Nearly two million people use a continuous glucose monitor today, and the ability to capture […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Preliminary 2022 Operating Results, Eyes Continued Growth of B2B Revenue
February 6, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today released preliminary unaudited revenue results for the fourth quarter and full year 2022 of approximately $6.7 million and $27.5 million, respectively. According to the update, expected fourth quarter revenue shows a consecutive increase relative to the third quarter of 2022 ($6.6 million), […]